Clinical Trial Update: Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes [NA]

View source ↗

Summary

A clinical trial evaluating the efficacy and safety of duodenal mucosal resurfacing using the Revita device for inadequately controlled type 2 diabetes is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Revita

Snippet

Sponsor: Fractyl Health Inc. | Conditions: Type 2 Diabetes | NA | Status: SUSPENDED